会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BONE SUBSTITUTE MATERIAL
    • 骨代替材料
    • WO2010149296A1
    • 2010-12-29
    • PCT/EP2010/003590
    • 2010-06-15
    • GEISTLICH PHARMA AGBUFLER, Michael, Alexander
    • BUFLER, Michael, Alexander
    • A61L27/12A61L27/32A61L27/42A61L24/00A61L31/02A61L31/08A61L31/12
    • A61L27/425A61L24/0063A61L27/12A61L27/32A61L27/50A61L31/026A61L31/086A61L31/123A61L2400/12A61L2430/02B33Y80/00
    • The invention relates to: - a biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material comprising a sintered CAP core and at least one uniform and closed epitactically grown layer of nanocrystalline HAP deposited on top of the sintered CAP core, whereby the epitactically grown nanocrystals have the same size and morphology as human bone mineral, i.e. a length of 30 to 46 nm and a width of 14 to 22 nm, - a process of preparing the above CAP/HAP bone substitute material comprising the steps of a) preparing a sintered CAP core material, b) immersing the sintered CAP core material in an aqueous solution at a temperature between 10°C and 50°C to start the transformation process of CAP to HAP whereby a uniform and closed epitactic grown layer of nanocrystalline hydroxyapatite will be formed on the CAP core material surface, the epitactically grown nanocrystals having the same size and morphology as human bone mineral, c) stopping the transformation by separating solid material from the aqueous solution at a time when a uniform and closed coating of at least one nanocrystalline layer of HAP is present but before the transformation process is finished completely, and d) optionally sterilizing the separated material coming from step c), and - the use of the above bone substitute material as implant or prosthesis for bone formation, bone regeneration, bone repair and/or bone replacement at a defect site in a human or animal.
    • 本发明涉及: - 双相磷酸钙/羟基磷灰石(CAP / HAP)骨替代材料,其包含烧结的CAP芯和沉积在烧结的CAP芯的顶部上的至少一个均匀和封闭的纳米晶体HAP的外延生长层,其中, 生长的纳米晶体具有与人骨矿物相同的尺寸和形态,即30至46nm的长度和14至22nm的宽度, - 制备上述CAP / HAP骨替代材料的方法,包括以下步骤:a)制备 烧结的CAP芯材料,b)将烧结的CAP芯材浸入在10℃至50℃的温度下的水溶液中以开始CAP转化为HAP,由此使纳米晶体羟基磷灰石的均匀和封闭的外延生长层将 形成在CAP芯材表面上,具有与人骨矿物相同尺寸和形态的外延生长的纳米晶体,c)通过分离固体m停止转化 当存在至少一个HAP的至少一个纳米晶层的均匀和封闭的涂层时,但是在转化过程完全完成之前,从水溶液中的空气,以及d)任选地对来自步骤c)的分离的材料进行灭菌,以及 - 使用上述骨替代材料作为人或动物的缺损部位的骨形成,骨再生,骨修复和/或骨置换的植入物或假体。